Meet The Team

James Sidaway

PhD

James is an experienced and innovative toxicologist, having worked for over 20 years in the pharmaceutical industry with AstraZeneca and as an independent consultant. As a molecular-investigative toxicologist, he helped resolve safety issues for a wide range of drug discovery and development projects across the major therapy areas. He has also developed advanced in vitro models for organ toxicity screening, pioneered the application of novel technology and informatics platforms and has a strong track record of delivering Target Safety Assessments (TSAs).

James leads our rapidly growing Safety Science Group that delivers Acuity TSAs and related data-oriented toxicology services and products. He enjoys developing team expertise and bringing new and diverse skillsets and capabilities to the fold, including in data science. James is a member of the HESI Working Group for the Safety of Targeted Protein Degraders and regularly publishes in peer-reviewed journals, including a 2026 article in Nature Reviews Drug Discovery.